[EN] DISUBSTITUTED PYRAZOLE COMPOUNDS AS KETOHEXOKINASE INHIBITORS<br/>[FR] COMPOSÉS PYRAZOLE DISUBSTITUÉS UTILISÉS EN TANT QU'INHIBITEURS DE CÉTOHEXOKINASE
申请人:LILLY CO ELI
公开号:WO2020257171A1
公开(公告)日:2020-12-24
The present invention provides a compound of Formula I: or a pharmaceutically acceptable salt thereof, and the use of compounds of Formula I for treating metabolic conditions, such as type 2 diabetes mellitus, heart failure, diabetic kidney disease, and non-alcoholic steatohepatitis.